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Juvenile xanthogranuloma is a non-Langerhans cell histiocytosis seen most commonly in childhood and
adolescence. Extracutaneous involvement is rare. We report an interesting and extremely rare case of
systemic (skin, lung, spleen, and colon) “juvenile xanthogranuloma” in the neonatal period. Our case was
the ﬁrst ever reported case born to a cross-cousin marriage.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Juvenile xanthogranuloma (JXG) is a rare disease of unknown eti-
ology, which belongs to non-Langerhans cell histiocytosis group.1 It
is a benign, generally asymptomatic condition, most frequently
seen in early childhood.2 In systemic JXG, involvement of the
mucosal surfaces, central nervous system, gastrointestinal tract,
eye, kidney, liver, spleen, lung, testis, lymph node, muscle, and bone
marrow may be seen.3e5 Here, we report on a 3-month-old baby
born to a cross-cousin marriage. When the baby was 10 days old,
subcutaneous nodules were noted and eventually diagnosed as
JXG. Histopathological examination revealed involvement of the
lungs, spleen, and gastrointestinal system.
Case report
The patient was admitted to our hospital at the age of 3 months,
because of painless swelling behind the ear and cervical region. It
was the third child of the family. No problem was detected in they have no ﬁnancial or non-
atter or materials discussed
ospital, Department of Pedi-
35220, Turkey.
lu).
cal Association. Published by Elsevperinatal period. Family history revealed that parents were cousins,
and the siblings, aged 7 years and 9 years, were both healthy
(Figure 1). The patient's growth was normal and appropriate with
the age. A nodule (1  1.5 cm2 in size) was observed at the left
retroauricular region that healed with scarring and another
(1  1 cm2 in size) at the right anterior cervical region. Other sys-
tems were normal. Laboratory ﬁndings were in normal ranges,
except for low hemoglobin (7.1 g/dL) and hematocrit (21%), and
high erythrocyte sedimentation rate (105 mm/hour) and C-reactive
protein (4.83 mg/L). Tests for TORCH infections (Toxoplasmosis,
Other Agents, Rubella, Cytomegalovirus, Herpes Simplex) and tuber-
culosis were negative, and lymphocyte panel and burst suppression
were normal. A chest radiograph revealed bilateral pulmonary
nodules and interstitial inﬁltrates, and this prompted a computer-
ized tomographic examination. Thoracic CT (computed tomogra-
phy) revealed cavitary lesions, with thick walls and cystic zones, of
different dimensions at different locations in both lungs (Figure 2).
Bone marrow was normal. Abdominal ultrasonography demon-
strated multiple solitary hypoechoic nodules in the spleen.
Fundoscopic examination, cranial magnetic resonance, echocardi-
ography, and head and long bone X-rays were normal. During the
course of the disease, melena was detected and granular lesions
were seen at transverse, sigmoid colons and rectum by colonos-
copy. Lung biopsy revealed disseminated histiocytic inﬁltration at
the parenchyma and a number of necrotic granulomas. Immuno-
phenotypically, most of the histiocytic cells were positive for CD68ier Taiwan LLC. All rights reserved.
Figure 1 Family pedigree of the patient (1: our case).
Figure 2 Nodular lesions with thick walls and cystic zones in the lung parenchyma.
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skin biopsies from the cutaneous lesions, the same histiocytic in-
ﬁltrations were detected with CD68-positive, S-100-negative, and
CD1a-negative staining (Figure 4).
Prednisone and vinblastine were started with the diagnosis of
systemic JXG. During the 1st month of chemotherapy, abdominalFigure 3 (A) CD68-positive histiocytes and (B) Cultrasonography revealed a decrease in the nodular lesions of the
spleen and lungs. However, the child died because of respiratory
failure following pneumonia during the 2nd month of treatment.Discussion
Because the most prominent ﬁnding of our patient was diffuse
cavitary lesions in the lung, differential diagnosis was focused on
this ﬁnding. Multifocal or diffuse involvement with cavitary lesions
may be seen in neoplasms (bronchogenic cancer, lymphoma, and
metastasis), many types of infectious processes and abscesses,
pulmonary infarct, septic embolism, vasculitis, congenital abnor-
malities, rheumatoid nodule, and pulmonary Langerhans cell his-
tiocytosis.6 In our case, as the symptoms initially started in the
neonatal period, the most probable reasons ruled out were infec-
tious processes, septic embolism, congenital abnormalities, and
pulmonary Langerhans cell histiocytosis. Eventual diagnosis of JXG,
which is an extremely rare condition, was made by histopatho-
logical examination.
Contemporarily, it has not yet been clariﬁed whether JXG is a
reactive or a pathological disorder.2 Viral infections such as Cyto-
megalovirus (CMV) or Varicella has been thought as the trigger
factor in some cases.3,7,8 Neuroﬁbromatosis type 1 (NF1) and ju-
venile chronic myeloid leukemia may accompany JXG. The inci-
dence of NF1 with JXG is 0.7e18%.9. Zvulunov et al10 have reported
that the incidence of juvenile chronic myeloid leukemia increases
with JXG and NF1 concomitance. In our patient, there were no
clinical, radiological, or laboratory ﬁndings that support the diag-
nosis of NF1 or juvenile chronic myeloid leukemia. TORCH serology
was found to be negative in our case.
Typically, cutaneous ﬁndings of JXG include smooth, nontender,
reddish-brown papules and nodules ranging from 1 mm to 10 mm
up to 4 cm. Lesions are mostly located in the head, neck, and upper
trunk areas. Frequently detected solitarily in children, they can be
multiple as well. In two big case series regarding JXG, solitary
cutaneous lesions were detected in 67% and 71% of cases, multiple
cutaneous lesions in 7% and 10%, soft tissue lesions in 16% and 15%,
and systemic lesions in 4% and 5%.3,4
Extracutaneous manifestations of JXG are not very frequent;
they may occur in 5% of cases. Freyer et al11 found a total of 36
patients, including two of their own cases. The most common sites
of extracutaneous involvement were subcutaneous soft tissue (in
33.3% of the cases), central nervous system (22.2%), liver/spleen
(22.25%), lung (16.6%), eye/orbit (11.1%), and oropharynx and
muscle (11.1% each). Although these extracutaneous lesions are of a
benign nature, signiﬁcant problems may arise due to pressure ef-
fects and possible clinical misdiagnosis as malignant entities.3,4,12,13
Involvement of the central nervous system and liver was reportedD1a-negative histiocytes (DAB stain, 400).
Figure 4 Histiocytic proliferation at dermis (hematoxylin and eosin stain, 40).
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manifests as bilateral, diffuse, asymptomatic micro- or macro-
nodules.11,16,17 Interstitial lung pattern and mediastinal adenopathy
have been reported.18 Our case had cavitary lesions, which were an
atypical form of pulmonary involvement, distinct from the classical
pattern of lung involvement described in the literature. Besides,
abdominal ultrasonography revealed spleen involvement. Colon
lesions were detected with biopsy.
JXG cells show a consistent immunoreactivity for vimentin,
CD68, factor XIIIa, and CD163, and are negative for S-100, CD1a, and
langerin.12,19,20 Histiocytic inﬁltrations of the dermis have been
detected in the skin biopsies; moreover, lung and colon biopsies
conﬁrmed the diagnosis of JXG histopathologically and
immunohistochemically.
Although JXG is a benign condition, systemic involvement may
cause morbidity and mortality.21,22 Consequently, vinblastin,
vincristine, cytarabine, methotrexate, prednisone, and 6-mercap-
topurin are used for treatment.23 Our case had a systemic disease
with lung, colon, and spleen involvement; therefore, chemotherapy
with prednisone and vinblastin was started. However, the child
died in the 2nd month of treatment as a result of respiratory failure
due to pneumonia.
Cross-cousin marriage is frequently seen in Turkey; therefore,
we often perform genetic investigations when we encounter rare
cases with a history of cross-cousin marriage. Since our case was
born to a cross-cousin marriage, genetic investigations should have
also been performed. However, it is considerably costly and lengthy
to explore a genetic anomaly for the ﬁrst time that was not deﬁned
earlier. Hence, we were not able to explore it.
In conclusion, in the differential diagnosis of pulmonary cavitary
lesions, non-Langerhans cell histiocytosis should be considered in
addition to Langerhans cell histiocytosis. It should also be noted
that JXG may present in the neonatal period with systemic
involvement.We propose that there can be a genetic predisposition
in the etiology of early-onset systemic JXG.References
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